Sameer Lolyekar, from Duncanville, Texas, used to smoke about 15 cigarettes a day until a few months ago. After visiting Mumbai, India, he switched to Maruk, a new herbal cigarette brand based in Pune, and cut his smoking in half. He has since introduced many friends and family members to the brand, and due to increasing demand, has become Maruk's first official importer and distributor in the United States.
Similarly, a year and a half ago, while constantly traveling between Pune and Mumbai, he used to smoke 10 cigarettes a day. With the use of Maruk, he has almost quit smoking. The health benefits of Maruk far outweigh the satisfaction of nicotine addiction.
AnantVed Research Lab (AVRL) has recently become the first company in the country to obtain a patent for herbal tobacco and has launched herbal cigarettes named Maruk and Tamburini. Additionally, for those accustomed to chewing tobacco, the company has invented an herbal cigarette that has proven to be a suitable alternative tobacco product. Founder Dr. Rajas stated that AVRL has been conducting Ayurvedic research for 70 years and the company holds a market share of 100 million rupees.
Some doctors have started using these products for treatment, not only in India but also sold overseas through online retail. Manohar Kamath from Indico Ventures Lab has joined AVRL. Currently, there are four to five different brands operating in the Indian market, but Maruk is the first to receive a patent.
In India, smoking is a prevalent behavior and a significant cause of throat and mouth cancers. Goodka is also a herbal alternative to cigarettes produced by AVRL. It contains a mix of Ayurvedic herbs, seeds, and dehydrated fruits, along with natural oils that provide a stimulating and energizing effect. Dr. Rajas notes that these ingredients aid digestion, reduce acidity, and act as a mouth freshener.
What's more, the new product can be inhaled with no side effects and completely eliminates the threat of secondhand smoke. The product has been approved by the Food and Drug Administration (FDA) and is in the final stages of patenting," revealed Kamath. In addition to being sold by online retailers such as Amazon, Flipkart, and Meeshow, Maruk is currently available in Mumbai, Bangalore, Mahabalipuram, and Goa.
Due to his own struggles with respiratory congestion and his experimentation with Ayurvedic smoke therapy, he began developing his own herbal formulas and inhaling smoke to alleviate symptoms. Through his experiments, he developed new herbal blends and treatment methods and was able to help several individuals recover from their ailments. Today, he is affectionately referred to as the "Father of Herbal Smoke Therapy.
Statement
This article is compiled from third-party information and is intended solely for industry exchange and learning.
This article does not represent the views of 2FIRSTS and 2FIRSTS is also unable to confirm the authenticity and accuracy of the content. The translation of this article is only used for industry communication and research purposes.
Due to limitations in translation abilities, the translated article may not fully capture the original meaning. Please refer to the original article for accuracy.
2FIRSTS completely aligns with the Chinese government on any domestic, Hong Kong, Macau, Taiwan and foreign-related issues and stances.
Information compilation copyright belongs to original media and authors. If there is any infringement, please contact for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
